Identification and characterization of the Plasmodium vivax thrombospondin-related apical merozoite protein
2010

Identifying and Characterizing the Plasmodium vivax TRAMP Protein

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): Mongui Alvaro, Angel Diana I, Moreno-Perez Darwin A, Villarreal-Gonzalez Silvana, Almonacid Hannia, Vanegas Magnolia, Patarroyo Manuel A

Primary Institution: Fundación Instituto de Inmunología de Colombia (FIDIC)

Hypothesis

This study aims to identify and characterize the PfTRAMP homologue in P. vivax, known as PvTRAMP, and evaluate its potential as a vaccine candidate.

Conclusion

The study found that PvTRAMP is conserved and recognized by the immune system during natural P. vivax infections, suggesting its potential as a vaccine target.

Supporting Evidence

  • PvTRAMP is a 340-amino-acid long antigen that is recognized by the immune system during P. vivax infections.
  • The protein is initially located at the parasite's apical end and later on the surface.
  • Recombinant PvTRAMP was recognized by sera from infected patients, indicating its immunogenic potential.

Takeaway

Researchers found a protein in the malaria parasite that could help the body fight the disease, and they think it might be useful for making a vaccine.

Methodology

The study involved gene identification, protein expression in E. coli, and immunological assays to assess recognition by sera from infected individuals.

Limitations

The study primarily focused on a single strain of P. vivax and may not represent all strains.

Participant Demographics

Participants were individuals from a P. vivax malaria endemic area in Colombia.

Digital Object Identifier (DOI)

10.1186/1475-2875-9-283

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication